N Verses Capital, LLC Atri Cure, Inc. Transaction History
N Verses Capital, LLC
- $167 Billion
- Q2 2024
A detailed history of N Verses Capital, LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 600 shares of ATRC stock, worth $16,932. This represents 0.01% of its overall portfolio holdings.
Number of Shares
600Holding current value
$16,932% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ATRC
# of Institutions
210Shares Held
49.3MCall Options Held
111KPut Options Held
23.8K-
Vanguard Group Inc Valley Forge, PA4.62MShares$130 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$130 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY4.2MShares$119 Million0.03% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.67MShares$75.5 Million0.39% of portfolio
-
Macquarie Group LTD Australia, C32MShares$56.4 Million0.05% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.31B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...